MORE►
biotech
Romulus and Remus, shown here at three months, turned six months old in April. The twin male dire wolves are the world’s first successfully de-extinct animals. Born from ancient DNA and modern science, they now roam a secure preserve in an ice age comeback story. [Photo: Colossal]
Hear the Howl: Dallas De‑Extinction Company Colossal Biosciences Brings Back Dire Wolf Using Ancient DNA
by Quincy Preston | Apr 7, 2025
“Game of Thrones” made them famous, but the prehistoric dire wolves were real—and, according to Colossal Biosciences, have now returned after 12,500 years in what it calls the world’s first successful de-extinction. The work goes beyond headlines: It could change how we save endangered species.
Meet Romulus, Remus, and Khaleesi in a video—and hear dire wolf howls for the first time in more than 12 millennia.
by Nicole Ward, DRC Data Journalist |
Mar 27, 2025
Eido Bio’s three co-founders are taking on menopause, research gaps, and a market where women’s health “sort of starts and stops with birth control.” The biotech startup is raising a Series A to launch clinical trials for a menopause treatment—and help shift the science toward women.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Jan 9, 2025
Virbac said that URSOLYX Soft Chews target mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic acid to enhance muscle function and strength in aging, active, or recovering dogs.
MORE►
Carter Inc. during a move at Pegasus Park in Dallas. [Photo: Carter Inc.]
From Research Labs to Operating Rooms, Dallas-Based Carter Inc. Packs Up Success for Critical Relocations
by Nicole Ward, DRC Data Journalist | Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Nicole Ward, DRC Data Journalist |
Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
MORE►
by Quincy Preston |
Mar 5, 2024
According to a new report from Dallas-based JLL, society is accelerating the volume of data it creates at a rapid rate—and that data is foundational to how we work, live, and play. That's led to sharply increasing demand for data centers in a time of tightening supply, forcing a shift toward secondary and new, emerging markets.
MORE►
by Quincy Preston |
Oct 16, 2023
The NFL and NBA icons—Clark Hunt and Dirk Nowitzki—will kick off and wrap up discussions on innovation and investment. They add to an "impressive speaker lineup" including Nextdoor Co-Founder Nirav Tolia and other trailblazing speakers. Here's the full roster.
MORE►
Speakers and tracks are still being unveiled for the Venture Dallas 2023 Summit. Confirmed speakers include (clockwise from upper left): AT&T's Vikram Taneja, Beautybio Founder Jamie O'Banion, Bestow's Melbourne O'Banion, Dialexa/IBM's Scott Harper, investor and Nextdoor founder Nirav Tolia, Rosy Wellness' Lyndsey Harper, Topgolf's Artie Starrs, and PGA's Arjun Chowdri. [Courtesy photos]
‘Innovation Meets Investment’: Venture Dallas Sets Sights on National Stage with New Branding, Expanded 2023 Summit
by Quincy Preston | Sep 27, 2023
The rebrand "marks the start of our next chapter of growth," says Venture Dallas Chair Aaron Pierce. The nonprofit's 2023 summit, backed by JPMorgan Chase and Perot Jain, is set for October 25.
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by Dallas Innovates | Staff Report |
Jul 28, 2023
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines," said Richard Meserole, president of Fluor’s advanced technologies and life sciences business.
MORE►
by Quincy Preston |
Jul 26, 2023
From an old car parts garage, Vertex Founder Joshua Boger launched the Boston-based biotech giant in 1989, running it for two decades as CEO. Boger "unretired" in June to join fast-moving Alkeus Pharmaceuticals as executive chairman.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
In Dallas, he shared the "mistakes" that led to his success with innovators at Pegasus Park. Here's his no-holds-barred dose of truth for all entrepreneurs.
MORE►
Elina Lavit [Illustration: DI, courtesy photo]
A Fork in the Road Leads to Opportunity in Dallas-Fort Worth
by Nicole Ward, DRC Data Journalist | Jun 8, 2023
Elina Lavit, originally from the Soviet Union, charted a new course in 2021. Swapping San Francisco for Dallas, she's now steering business development at OncoNano Medicine, a North Texas biotech that aims to revolutionize cancer treatment.
MORE►
by Lance Murray |
Jun 6, 2023
VanTrust Real Estate, which has an office in Dallas, has announced a new division that is designed to match its real estate expertise and capital resources with both public and private sector clients in the life sciences, R&D, institutional, governmental, biotech, pharmaceutical and technology industries....
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Quincy Preston |
May 18, 2023
The multi-billion investment firm’s two-property industrial deal in Philadelphia builds on its commitment to grow in the “critical sector.” Closer to home, NexPoint recently unveiled plans for a massive life sciences district in Plano. The proposed 200-acre TxS development would be a "major economic catalyst" for North Texas, the firm’s founder said in February.
MORE►
